Back

Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab

31 August 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Cardiotoxicity and development of heart failure Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Nilda Espinola-Zavaleta

National Institute of Cardiology Ignacio Chavez, Mexico City (Mexico)

7 More presentations in this session

Presentation thumbnail
Low clinical utility of global longitudinal strain in a real-world breast cancer population
Doctor L. Ruane (Brisbane, AU)
Abstract Slides Video
Presentation thumbnail
Does HFpEF represent a risk factor and a marker of cardiotoxicity in patients undergoing cancer treatment?
Doctor B. von Kemp (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Angiotensin receptor-neprilysin inhibitor (Sacubitril/Valsartan) in cancer therapy-related cardiac dysfunction: real-world experience from a nurse-led cardio-oncology clinic
Miss P. Reehal (London, GB)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics, resource use, and diagnostic accuracy of natriuretic peptides in cancer patients presenting with acute dyspnea to the Emergency Department
Doctor P. Lopez Ayala (Basel, CH)
Abstract Slides Video
Presentation thumbnail
miRNAs profile as a signature for cardiovascular disease in long-term breast cancer female survivors: a pilot study
Doctor A. Greatti (Ferrara, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiotoxicity and development of heart failure

The Event

Event poster

ESC Congress 2024

31 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Prospective study of impact of numbers of cardiotoxic chemotherapy and frequency on arrhythmia occurrence in patients with breast cancer
thumbnail
Congress Presentation
Decoding chemotherapy-related cardiac dysfunction prediction: left ventricular strain imaging or HFA-ICOS score?
thumbnail
Congress Presentation
Update on cardiotoxicity in breast cancer: challenges and clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources